Health Technology Assessments for the Swiss Medical Board
Research Project | 01.06.2014 - 31.12.2021
|
01.06.2014
- 31.12.2021
Funding
Health Technology Assessments for the Swiss Medical Board
Industriegelder, Sonstige Forschungskooperationen (GrantsTool), 06.2014-12.2016 (31)
PI : Schwenkglenks, Matthias.
Publications
Barbier, Michaela C et al. (2022) ‘Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer’, PLoS ONE, 17(11 November), p. e0277282. Available at: https://doi.org/10.1371/journal.pone.0277282.
Barbier, Michaela C et al. (2022) ‘Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer’, PLoS ONE, 17(11 November), p. e0277282. Available at: https://doi.org/10.1371/journal.pone.0277282.
Members (5)
Heiner Bucher
Principal Investigator
Matthias Schwenkglenks
Principal Investigator
Zanfina Ademi
Project Member
Michaela Barbier
Project Member